PCLX-001

• Description:

  PCLX-001 is a small-molecule compound that acts as an orally active inhibitor of N-myristoyltransferase (NMT), specifically targeting NMT1 and NMT2 with IC50 values of 5 nM and 8 nM, respectively. This compound demonstrates anti-tumor effects and effectively inhibits the early signaling of B-cell receptor (BCR) . Consequently, PCLX-001 is a valuable tool for researching B-cell malignancies .

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  537.51

• Molecular Formula:

  C24H30Cl2N6O2S

• Notes:

  Research use only, not for human use.

• Receptor:

  Others

• CAS Number:

  1215011-08-7